Lipid-lowering medication reduces more target lesion than non-target lesion revascularizations: a cohort study.

ABSTRACT:

Background

Factors related to the very long-term progression of atherosclerosis after stent implantation remain unclear.

Aims

To define factors predicting disease progression as either target lesion (TL) or a new site target lesion (NTL) coronary stenosis.

Methods

In a tertiary hospital, between June 2006 and March 2008, a prospective cohort registry of consecutive patients assigned to a coronary angiogram (n = 5294) was collected. Patients who underwent percutaneous coronary stenting (n = 1970 patients) were followed for ten years. Of them (1335/67.8%) had acute coronary syndrome (ACS) and (635/32.2%) chronic coronary syndrome (CCS). New ischemic lesions were categorized as TL or NTL.

Results

During a median of 9.5 years follow-up, 639 (32.4%) pa

SUBMITTER: Mantyniemi E 

PROVIDER: S-EPMC12912242 | biostudies-literature | 2026 Dec

REPOSITORIES: biostudies-literature